Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 2 | 2023 | 440 | 1.070 |
Why?
|
| Point-of-Care Systems | 5 | 2022 | 1177 | 0.780 |
Why?
|
| Cannabinoids | 1 | 2023 | 166 | 0.750 |
Why?
|
| Glucose | 2 | 2022 | 4398 | 0.710 |
Why?
|
| Laboratories, Hospital | 1 | 2020 | 194 | 0.660 |
Why?
|
| Hallucinogens | 1 | 2021 | 177 | 0.650 |
Why?
|
| Clinical Chemistry Tests | 1 | 2018 | 61 | 0.640 |
Why?
|
| Hemolysis | 2 | 2016 | 420 | 0.580 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2020 | 1156 | 0.540 |
Why?
|
| Lactic Acid | 3 | 2021 | 1131 | 0.530 |
Why?
|
| Chromatography, Liquid | 2 | 2020 | 975 | 0.530 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 1020 | 0.500 |
Why?
|
| Blood Specimen Collection | 1 | 2016 | 246 | 0.500 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2015 | 108 | 0.500 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 440 | 0.500 |
Why?
|
| Health Literacy | 1 | 2020 | 414 | 0.490 |
Why?
|
| Cobalt | 1 | 2014 | 158 | 0.490 |
Why?
|
| Hypercalcemia | 1 | 2017 | 409 | 0.480 |
Why?
|
| Disaster Planning | 1 | 2020 | 548 | 0.480 |
Why?
|
| Communicable Diseases | 1 | 2022 | 880 | 0.470 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 934 | 0.470 |
Why?
|
| Outpatients | 1 | 2021 | 1488 | 0.460 |
Why?
|
| Quality Control | 1 | 2016 | 841 | 0.450 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 135 | 0.440 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1968 | 0.410 |
Why?
|
| Erythrocytes | 2 | 2013 | 2455 | 0.400 |
Why?
|
| Specimen Handling | 1 | 2016 | 694 | 0.400 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 738 | 0.390 |
Why?
|
| Oxygen | 1 | 2023 | 4189 | 0.390 |
Why?
|
| Income | 1 | 2020 | 1913 | 0.380 |
Why?
|
| Blood Glucose | 2 | 2022 | 6259 | 0.370 |
Why?
|
| Legislation, Drug | 2 | 2023 | 206 | 0.370 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2016 | 778 | 0.350 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 1029 | 0.340 |
Why?
|
| Luminescence | 1 | 2009 | 137 | 0.320 |
Why?
|
| Hip Prosthesis | 1 | 2014 | 917 | 0.320 |
Why?
|
| Antibodies, Viral | 4 | 2023 | 3175 | 0.310 |
Why?
|
| Reference Standards | 2 | 2022 | 1023 | 0.270 |
Why?
|
| Vitamin D | 2 | 2020 | 3222 | 0.270 |
Why?
|
| Laboratories | 3 | 2021 | 462 | 0.230 |
Why?
|
| Computational Biology | 1 | 2015 | 3515 | 0.220 |
Why?
|
| Colorado | 1 | 2023 | 163 | 0.220 |
Why?
|
| Humans | 36 | 2023 | 743811 | 0.210 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 634 | 0.210 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 14714 | 0.210 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 828 | 0.210 |
Why?
|
| Oxyhemoglobins | 1 | 2023 | 216 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3134 | 0.210 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 1978 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.210 |
Why?
|
| Physicians | 1 | 2020 | 4569 | 0.200 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2020 | 39 | 0.190 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 101 | 0.190 |
Why?
|
| Immunoassay | 3 | 2021 | 751 | 0.190 |
Why?
|
| Immunoglobulin M | 2 | 2023 | 1537 | 0.190 |
Why?
|
| Metabolomics | 1 | 2009 | 1487 | 0.180 |
Why?
|
| Oximetry | 1 | 2023 | 471 | 0.180 |
Why?
|
| Acidosis | 1 | 2021 | 271 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 995 | 0.170 |
Why?
|
| Creatinine | 2 | 2021 | 1918 | 0.170 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 435 | 0.170 |
Why?
|
| Bicycling | 1 | 2020 | 176 | 0.170 |
Why?
|
| Health Planning | 1 | 2020 | 237 | 0.160 |
Why?
|
| Immune Evasion | 1 | 2022 | 360 | 0.160 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 263 | 0.150 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 19894 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 582 | 0.140 |
Why?
|
| United States | 5 | 2023 | 69859 | 0.140 |
Why?
|
| Calcitonin | 1 | 2017 | 336 | 0.130 |
Why?
|
| Automobile Driving | 1 | 2020 | 430 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2020 | 819 | 0.120 |
Why?
|
| Analgesics | 1 | 2021 | 1040 | 0.120 |
Why?
|
| Canada | 1 | 2020 | 2064 | 0.120 |
Why?
|
| Erythrocyte Count | 1 | 2014 | 163 | 0.120 |
Why?
|
| Biological Assay | 1 | 2017 | 650 | 0.120 |
Why?
|
| Emergency Service, Hospital | 3 | 2023 | 7658 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 4561 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2017 | 1588 | 0.110 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 270 | 0.110 |
Why?
|
| Walking | 1 | 2020 | 1182 | 0.110 |
Why?
|
| CA-19-9 Antigen | 1 | 2013 | 112 | 0.110 |
Why?
|
| Sepsis | 2 | 2017 | 2593 | 0.110 |
Why?
|
| Pandemics | 3 | 2022 | 8385 | 0.110 |
Why?
|
| alpha-Fetoproteins | 1 | 2013 | 223 | 0.110 |
Why?
|
| Immobilized Proteins | 1 | 2011 | 25 | 0.100 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2013 | 349 | 0.100 |
Why?
|
| Leukocyte Rolling | 1 | 2011 | 72 | 0.100 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 798 | 0.100 |
Why?
|
| Ascites | 1 | 2013 | 344 | 0.100 |
Why?
|
| Acetabulum | 1 | 2014 | 525 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1582 | 0.090 |
Why?
|
| Data Mining | 1 | 2015 | 537 | 0.090 |
Why?
|
| Pelvis | 1 | 2014 | 730 | 0.090 |
Why?
|
| Hepacivirus | 1 | 2017 | 1378 | 0.090 |
Why?
|
| Linear Models | 2 | 2018 | 5952 | 0.090 |
Why?
|
| Polycarboxylate Cement | 1 | 2009 | 18 | 0.090 |
Why?
|
| Antibodies | 1 | 2017 | 2459 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2017 | 2901 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2014 | 899 | 0.080 |
Why?
|
| Self Report | 1 | 2020 | 3550 | 0.080 |
Why?
|
| P-Selectin | 1 | 2011 | 601 | 0.080 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2009 | 149 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2013 | 1728 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2015 | 1546 | 0.080 |
Why?
|
| Porosity | 1 | 2009 | 360 | 0.080 |
Why?
|
| NADP | 1 | 2009 | 226 | 0.080 |
Why?
|
| Hospitals | 1 | 2022 | 3953 | 0.080 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 371 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3391 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2013 | 1531 | 0.070 |
Why?
|
| Fluorescence | 1 | 2009 | 752 | 0.070 |
Why?
|
| Glutathione | 1 | 2009 | 590 | 0.070 |
Why?
|
| Calibration | 1 | 2009 | 816 | 0.070 |
Why?
|
| Sex Factors | 1 | 2020 | 10394 | 0.070 |
Why?
|
| Aged | 4 | 2021 | 163178 | 0.070 |
Why?
|
| Adult | 4 | 2022 | 213889 | 0.060 |
Why?
|
| Female | 8 | 2021 | 380020 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3155 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5445 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 4254 | 0.060 |
Why?
|
| Calcium | 1 | 2017 | 5755 | 0.060 |
Why?
|
| Cell Death | 1 | 2009 | 1705 | 0.060 |
Why?
|
| Radiography | 1 | 2014 | 7010 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 2029 | 0.050 |
Why?
|
| Rabbits | 1 | 2009 | 4894 | 0.050 |
Why?
|
| Aspirin | 1 | 2014 | 3283 | 0.050 |
Why?
|
| Mass Screening | 1 | 2017 | 5251 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 3070 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10259 | 0.050 |
Why?
|
| Male | 7 | 2020 | 349776 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 263 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3769 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2022 | 841 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77410 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 576 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2022 | 2011 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 2556 | 0.040 |
Why?
|
| Workflow | 1 | 2021 | 847 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1127 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2570 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2021 | 1318 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2020 | 891 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1058 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 213241 | 0.030 |
Why?
|
| Vaccines | 1 | 2022 | 823 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2014 | 434 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2022 | 1940 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 2013 | 192 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 56392 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2011 | 115 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2022 | 5445 | 0.020 |
Why?
|
| Benzophenones | 1 | 2011 | 57 | 0.020 |
Why?
|
| Photochemical Processes | 1 | 2011 | 83 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2011 | 365 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 980 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2011 | 743 | 0.020 |
Why?
|
| Protein Binding | 1 | 2022 | 9377 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8316 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9310 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40038 | 0.020 |
Why?
|
| Video Recording | 1 | 2011 | 949 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9848 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 21675 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15211 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25609 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25032 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29777 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 168660 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 21733 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72252 | 0.010 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_